Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 847

1.

Suicide in Schizophrenia: An Educational Overview.

Sher L, Kahn RS.

Medicina (Kaunas). 2019 Jul 10;55(7). pii: E361. doi: 10.3390/medicina55070361. Review.

PMID:
31295938
Free Article
2.

B-cells and schizophrenia: A promising link or a finding lost in translation?

van Mierlo HC, Broen JCA, Kahn RS, de Witte LD.

Brain Behav Immun. 2019 Jul 2. pii: S0889-1591(19)30484-2. doi: 10.1016/j.bbi.2019.06.043. [Epub ahead of print] Review.

PMID:
31271869
3.

The Promise of Precision Population Health: Reducing Health Disparities Through a Community Partnership Framework.

Kuo AK, Summers NM, Vohra S, Kahn RS, Bibbins-Domingo K.

Adv Pediatr. 2019 Aug;66:1-13. doi: 10.1016/j.yapd.2019.03.002. Epub 2019 Apr 26. Review. No abstract available.

PMID:
31230687
4.

Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study.

Martinuzzi E, Barbosa S, Daoudlarian D, Ali WBH, Gilet C, Fillatre L, Khalfallah O, Troudet R, Jamain S, Fond G, Sommer I, Leucht S, Dazzan P, McGuire P, Arango C, Diaz-Caneja CM, Fleischhacker W, Rujescu D, Glenthøj B, Winter I, Kahn RS, Yolken R, Lewis S, Drake R, Davidovic L, Leboyer M, Glaichenhaus N; OPTiMiSE Study Group.

Transl Psychiatry. 2019 Jun 21;9(1):171. doi: 10.1038/s41398-019-0505-7.

5.

Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies.

Berdenis van Berlekom A, Muflihah CH, Snijders GJLJ, MacGillavry HD, Middeldorp J, Hol EM, Kahn RS, de Witte LD.

Schizophr Bull. 2019 Jun 13. pii: sbz060. doi: 10.1093/schbul/sbz060. [Epub ahead of print]

PMID:
31192350
6.

GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.

Mullins N, Bigdeli TB, Børglum AD, Coleman JRI, Demontis D, Mehta D, Power RA, Ripke S, Stahl EA, Starnawska A, Anjorin A; M.R.C.Psych, Corvin A, Sanders AR, Forstner AJ, Reif A, Koller AC, Świątkowska B, Baune BT, Müller-Myhsok B, Penninx BWJH, Pato C, Zai C, Rujescu D, Hougaard DM, Quested D, Levinson DF, Binder EB, Byrne EM, Agerbo E; Dr.Med.Sc, Streit F, Mayoral F, Bellivier F, Degenhardt F, Breen G, Morken G, Turecki G, Rouleau GA, Grabe HJ, Völzke H, Jones I, Giegling I, Agartz I, Melle I, Lawrence J; M.R.C.Psych, Walters JTR, Strohmaier J, Shi J, Hauser J, Biernacka JM, Vincent JB, Kelsoe J, Strauss JS, Lissowska J, Pimm J; M.R.C.Psych, Smoller JW, Guzman-Parra J, Berger K, Scott LJ, Jones LA, Azevedo MH, Trzaskowski M, Kogevinas M, Rietschel M, Boks M, Ising M, Grigoroiu-Serbanescu M, Hamshere ML, Leboyer M, Frye M, Nöthen MM, Alda M, Preisig M, Nordentoft M, Boehnke M, O'Donovan MC, Owen MJ, Pato MT, Renteria ME, Budde M; Dipl.-Psych, Weissman MM, Wray NR, Bass N; M.R.C.Psych, Craddock N, Smeland OB, Andreassen OA, Mors O, Gejman PV, Sklar P, McGrath P, Hoffmann P, McGuffin P, Lee PH, Mortensen PB, Kahn RS, Ophoff RA, Adolfsson R, Van der Auwera S, Djurovic S, Kloiber S, Heilmann-Heimbach S, Jamain S, Hamilton SP, McElroy SL, Lucae S, Cichon S, Schulze TG, Hansen T, Werge T, Air TM, Nimgaonkar V, Appadurai V, Cahn W, Milaneschi Y; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Fanous AH, Kendler KS, McQuillin A, Lewis CM.

Am J Psychiatry. 2019 Jun 5:appiajp201918080957. doi: 10.1176/appi.ajp.2019.18080957. [Epub ahead of print]

PMID:
31164008
7.

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, Young KL, Alfred T, Feitosa MF, Masca NGD, Manning AK, Medina-Gomez C, Mudgal P, Ng MCY, Reiner AP, Vedantam S, Willems SM, Winkler TW, Abecasis G, Aben KK, Alam DS, Alharthi SE, Allison M, Amouyel P, Asselbergs FW, Auer PL, Balkau B, Bang LE, Barroso I, Bastarache L, Benn M, Bergmann S, Bielak LF, Blüher M, Boehnke M, Boeing H, Boerwinkle E, Böger CA, Bork-Jensen J, Bots ML, Bottinger EP, Bowden DW, Brandslund I, Breen G, Brilliant MH, Broer L, Brumat M, Burt AA, Butterworth AS, Campbell PT, Cappellani S, Carey DJ, Catamo E, Caulfield MJ, Chambers JC, Chasman DI, Chen YI, Chowdhury R, Christensen C, Chu AY, Cocca M, Collins FS, Cook JP, Corley J, Galbany JC, Cox AJ, Crosslin DS, Cuellar-Partida G, D'Eustacchio A, Danesh J, Davies G, Bakker PIW, Groot MCH, Mutsert R, Deary IJ, Dedoussis G, Demerath EW, Heijer M, Hollander AI, Ruijter HM, Dennis JG, Denny JC, Di Angelantonio E, Drenos F, Du M, Dubé MP, Dunning AM, Easton DF, Edwards TL, Ellinghaus D, Ellinor PT, Elliott P, Evangelou E, Farmaki AE, Farooqi IS, Faul JD, Fauser S, Feng S, Ferrannini E, Ferrieres J, Florez JC, Ford I, Fornage M, Franco OH, Franke A, Franks PW, Friedrich N, Frikke-Schmidt R, Galesloot TE, Gan W, Gandin I, Gasparini P, Gibson J, Giedraitis V, Gjesing AP, Gordon-Larsen P, Gorski M, Grabe HJ, Grant SFA, Grarup N, Griffiths HL, Grove ML, Gudnason V, Gustafsson S, Haessler J, Hakonarson H, Hammerschlag AR, Hansen T, Harris KM, Harris TB, Hattersley AT, Have CT, Hayward C, He L, Heard-Costa NL, Heath AC, Heid IM, Helgeland Ø, Hernesniemi J, Hewitt AW, Holmen OL, Hovingh GK, Howson JMM, Hu Y, Huang PL, Huffman JE, Ikram MA, Ingelsson E, Jackson AU, Jansson JH, Jarvik GP, Jensen GB, Jia Y, Johansson S, Jørgensen ME, Jørgensen T, Jukema JW, Kahali B, Kahn RS, Kähönen M, Kamstrup PR, Kanoni S, Kaprio J, Karaleftheri M, Kardia SLR, Karpe F, Kathiresan S, Kee F, Kiemeney LA, Kim E, Kitajima H, Komulainen P, Kooner JS, Kooperberg C, Korhonen T, Kovacs P, Kuivaniemi H, Kutalik Z, Kuulasmaa K, Kuusisto J, Laakso M, Lakka TA, Lamparter D, Lange EM, Lange LA, Langenberg C, Larson EB, Lee NR, Lehtimäki T, Lewis CE, Li H, Li J, Li-Gao R, Lin H, Lin KH, Lin LA, Lin X, Lind L, Lindström J, Linneberg A, Liu CT, Liu DJ, Liu Y, Lo KS, Lophatananon A, Lotery AJ, Loukola A, Luan J, Lubitz SA, Lyytikäinen LP, Männistö S, Marenne G, Mazul AL, McCarthy MI, McKean-Cowdin R, Medland SE, Meidtner K, Milani L, Mistry V, Mitchell P, Mohlke KL, Moilanen L, Moitry M, Montgomery GW, Mook-Kanamori DO, Moore C, Mori TA, Morris AD, Morris AP, Müller-Nurasyid M, Munroe PB, Nalls MA, Narisu N, Nelson CP, Neville M, Nielsen SF, Nikus K, Njølstad PR, Nordestgaard BG, Nyholt DR, O'Connel JR, O'Donoghue ML, Loohuis LMO, Ophoff RA, Owen KR, Packard CJ, Padmanabhan S, Palmer CNA, Palmer ND, Pasterkamp G, Patel AP, Pattie A, Pedersen O, Peissig PL, Peloso GM, Pennell CE, Perola M, Perry JA, Perry JRB, Pers TH, Person TN, Peters A, Petersen ERB, Peyser PA, Pirie A, Polasek O, Polderman TJ, Puolijoki H, Raitakari OT, Rasheed A, Rauramaa R, Reilly DF, Renström F, Rheinberger M, Ridker PM, Rioux JD, Rivas MA, Roberts DJ, Robertson NR, Robino A, Rolandsson O, Rudan I, Ruth KS, Saleheen D, Salomaa V, Samani NJ, Sapkota Y, Sattar N, Schoen RE, Schreiner PJ, Schulze MB, Scott RA, Segura-Lepe MP, Shah SH, Sheu WH, Sim X, Slater AJ, Small KS, Smith AV, Southam L, Spector TD, Speliotes EK, Starr JM, Stefansson K, Steinthorsdottir V, Stirrups KE, Strauch K, Stringham HM, Stumvoll M, Sun L, Surendran P, Swift AJ, Tada H, Tansey KE, Tardif JC, Taylor KD, Teumer A, Thompson DJ, Thorleifsson G, Thorsteinsdottir U, Thuesen BH, Tönjes A, Tromp G, Trompet S, Tsafantakis E, Tuomilehto J, Tybjaerg-Hansen A, Tyrer JP, Uher R, Uitterlinden AG, Uusitupa M, Laan SW, Duijn CM, Leeuwen N, van Setten J, Vanhala M, Varbo A, Varga TV, Varma R, Edwards DRV, Vermeulen SH, Veronesi G, Vestergaard H, Vitart V, Vogt TF, Völker U, Vuckovic D, Wagenknecht LE, Walker M, Wallentin L, Wang F, Wang CA, Wang S, Wang Y, Ware EB, Wareham NJ, Warren HR, Waterworth DM, Wessel J, White HD, Willer CJ, Wilson JG, Witte DR, Wood AR, Wu Y, Yaghootkar H, Yao J, Yao P, Yerges-Armstrong LM, Young R, Zeggini E, Zhan X, Zhang W, Zhao JH, Zhao W, Zhao W, Zhou W, Zondervan KT; CHD Exome+ Consortium; EPIC-CVD Consortium; ExomeBP Consortium; Global Lipids Genetic Consortium; GoT2D Genes Consortium; EPIC InterAct Consortium; INTERVAL Study; ReproGen Consortium; T2D-Genes Consortium; MAGIC Investigators; Understanding Society Scientific Group, Rotter JI, Pospisilik JA, Rivadeneira F, Borecki IB, Deloukas P, Frayling TM, Lettre G, North KE, Lindgren CM, Hirschhorn JN, Loos RJF.

Nat Genet. 2019 Jul;51(7):1191-1192. doi: 10.1038/s41588-019-0447-2.

PMID:
31160809
8.

Differences between physicians' and nurse practitioners' viewpoints on reasons for clozapine underprescription.

Okhuijsen-Pfeifer C, Cohen D, Bogers JPAM, de Vos CMH, Huijsman EAH, Kahn RS, Luykx JJ.

Brain Behav. 2019 Jul;9(7):e01318. doi: 10.1002/brb3.1318. Epub 2019 May 29.

9.

Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated.

Sneeboer MAM, Snijders GJLJ, Berdowski WM, Fernández-Andreu A; Psychiatric Donor Program of the Netherlands Brain Bank (NBB-Psy), van Mierlo HC, Berdenis van Berlekom A, Litjens M, Kahn RS, Hol EM, de Witte LD.

Transl Psychiatry. 2019 May 24;9(1):153. doi: 10.1038/s41398-019-0490-x.

10.

DNA methylation changes related to nutritional deprivation: a genome-wide analysis of population and in vitro data.

He Y, de Witte LD, Houtepen LC, Nispeling DM, Xu Z, Yu Q, Yu Y, Hol EM, Kahn RS, Boks MP.

Clin Epigenetics. 2019 May 16;11(1):80. doi: 10.1186/s13148-019-0680-7.

11.

Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling.

van Rooijen G, van Rooijen M, Maat A, Vermeulen JM, Meijer CJ, Ruhé HG, de Haan L; GROUP investigators; Genetic Risk and Outcome of Psychosis investigators:, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Amelsvoort T, van Haren NE, van Os J, van Winkel R.

Schizophr Res. 2019 Jun;208:82-89. doi: 10.1016/j.schres.2019.04.011. Epub 2019 Apr 29.

PMID:
31047723
12.

Genome-wide association study identifies 30 loci associated with bipolar disorder.

Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, Pers TH, Holmans PA, Richards AL, Abbott L, Agerbo E, Akil H, Albani D, Alliey-Rodriguez N, Als TD, Anjorin A, Antilla V, Awasthi S, Badner JA, Bækvad-Hansen M, Barchas JD, Bass N, Bauer M, Belliveau R, Bergen SE, Pedersen CB, Bøen E, Boks MP, Boocock J, Budde M, Bunney W, Burmeister M, Bybjerg-Grauholm J, Byerley W, Casas M, Cerrato F, Cervantes P, Chambert K, Charney AW, Chen D, Churchhouse C, Clarke TK, Coryell W, Craig DW, Cruceanu C, Curtis D, Czerski PM, Dale AM, de Jong S, Degenhardt F, Del-Favero J, DePaulo JR, Djurovic S, Dobbyn AL, Dumont A, Elvsåshagen T, Escott-Price V, Fan CC, Fischer SB, Flickinger M, Foroud TM, Forty L, Frank J, Fraser C, Freimer NB, Frisén L, Gade K, Gage D, Garnham J, Giambartolomei C, Pedersen MG, Goldstein J, Gordon SD, Gordon-Smith K, Green EK, Green MJ, Greenwood TA, Grove J, Guan W, Guzman-Parra J, Hamshere ML, Hautzinger M, Heilbronner U, Herms S, Hipolito M, Hoffmann P, Holland D, Huckins L, Jamain S, Johnson JS, Juréus A, Kandaswamy R, Karlsson R, Kennedy JL, Kittel-Schneider S, Knowles JA, Kogevinas M, Koller AC, Kupka R, Lavebratt C, Lawrence J, Lawson WB, Leber M, Lee PH, Levy SE, Li JZ, Liu C, Lucae S, Maaser A, MacIntyre DJ, Mahon PB, Maier W, Martinsson L, McCarroll S, McGuffin P, McInnis MG, McKay JD, Medeiros H, Medland SE, Meng F, Milani L, Montgomery GW, Morris DW, Mühleisen TW, Mullins N, Nguyen H, Nievergelt CM, Adolfsson AN, Nwulia EA, O'Donovan C, Loohuis LMO, Ori APS, Oruc L, Ösby U, Perlis RH, Perry A, Pfennig A, Potash JB, Purcell SM, Regeer EJ, Reif A, Reinbold CS, Rice JP, Rivas F, Rivera M, Roussos P, Ruderfer DM, Ryu E, Sánchez-Mora C, Schatzberg AF, Scheftner WA, Schork NJ, Shannon Weickert C, Shehktman T, Shilling PD, Sigurdsson E, Slaney C, Smeland OB, Sobell JL, Søholm Hansen C, Spijker AT, St Clair D, Steffens M, Strauss JS, Streit F, Strohmaier J, Szelinger S, Thompson RC, Thorgeirsson TE, Treutlein J, Vedder H, Wang W, Watson SJ, Weickert TW, Witt SH, Xi S, Xu W, Young AH, Zandi P, Zhang P, Zöllner S; eQTLGen Consortium; BIOS Consortium, Adolfsson R, Agartz I, Alda M, Backlund L, Baune BT, Bellivier F, Berrettini WH, Biernacka JM, Blackwood DHR, Boehnke M, Børglum AD, Corvin A, Craddock N, Daly MJ, Dannlowski U, Esko T, Etain B, Frye M, Fullerton JM, Gershon ES, Gill M, Goes F, Grigoroiu-Serbanescu M, Hauser J, Hougaard DM, Hultman CM, Jones I, Jones LA, Kahn RS, Kirov G, Landén M, Leboyer M, Lewis CM, Li QS, Lissowska J, Martin NG, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Melle I, Metspalu A, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Neale BM, Nimgaonkar V, Nordentoft M, Nöthen MM, O'Donovan MC, Oedegaard KJ, Owen MJ, Paciga SA, Pato C, Pato MT, Posthuma D, Ramos-Quiroga JA, Ribasés M, Rietschel M, Rouleau GA, Schalling M, Schofield PR, Schulze TG, Serretti A, Smoller JW, Stefansson H, Stefansson K, Stordal E, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Werge T, Nurnberger JI, Wray NR, Di Florio A, Edenberg HJ, Cichon S, Ophoff RA, Scott LJ, Andreassen OA, Kelsoe J, Sklar P; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium.

Nat Genet. 2019 May;51(5):793-803. doi: 10.1038/s41588-019-0397-8. Epub 2019 May 1.

PMID:
31043756
13.

Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype.

Bossong MG, van Hell HH, Schubart CD, van Saane W, Iseger TA, Jager G, van Osch MJP, Jansma JM, Kahn RS, Boks MP, Ramsey NF.

Eur Neuropsychopharmacol. 2019 Jun;29(6):766-776. doi: 10.1016/j.euroneuro.2019.03.010. Epub 2019 Apr 8.

PMID:
30975584
14.

Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia.

Cui LB, Wei Y, Xi YB, Griffa A, De Lange SC, Kahn RS, Yin H, Van den Heuvel MP.

Schizophr Bull. 2019 Mar 30. pii: sbz014. doi: 10.1093/schbul/sbz014. [Epub ahead of print]

PMID:
30926985
15.

Volume increase in the dentate gyrus after electroconvulsive therapy in depressed patients as measured with 7T.

Nuninga JO, Mandl RCW, Boks MP, Bakker S, Somers M, Heringa SM, Nieuwdorp W, Hoogduin H, Kahn RS, Luijten P, Sommer IEC.

Mol Psychiatry. 2019 Mar 12. doi: 10.1038/s41380-019-0392-6. [Epub ahead of print]

PMID:
30867562
16.

Family interventions and prevention of suicide in first-episode schizophrenia.

Sher L, Kahn RS.

Acta Psychiatr Scand. 2019 May;139(5):484. doi: 10.1111/acps.13018.

PMID:
30839096
17.

Interhemispheric connectivity and hemispheric specialization in schizophrenia patients and their unaffected siblings.

Chang X, Collin G, Mandl RCW, Cahn W, Kahn RS.

Neuroimage Clin. 2019;21:101656. doi: 10.1016/j.nicl.2019.101656. Epub 2019 Jan 7.

18.

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study.

Martinuzzi E, Barbosa S, Daoudlarian D, Bel Haj Ali W, Gilet C, Fillatre L, Khalfallah O, Troudet R, Jamain S, Fond G, Sommer I, Leucht S, Dazzan P, McGuire P, Arango C, Diaz-Caneja CM, Fleischhacker W, Rujescu D, Glenthøj B, Winter I, Kahn RS, Yolken R, Lewis S, Drake R, Davidovic L, Leboyer M, Glaichenhaus N; OPTiMiSE Study Group.

Transl Psychiatry. 2019 Jan 17;9(1):20. doi: 10.1038/s41398-018-0366-5. Erratum in: Transl Psychiatry. 2019 Jun 21;9(1):171.

19.

Structural Thalamofrontal Hypoconnectivity Is Related to Oculomotor Corollary Discharge Dysfunction in Schizophrenia.

Yao B, Neggers SFW, Rolfs M, Rösler L, Thompson IA, Hopman HJ, Ghermezi L, Kahn RS, Thakkar KN.

J Neurosci. 2019 Mar 13;39(11):2102-2113. doi: 10.1523/JNEUROSCI.1473-18.2019. Epub 2019 Jan 10.

PMID:
30630882
20.

Multisensory integration underlying body-ownership experiences in schizophrenia and offspring of patients: a study using the rubber hand illusion paradigm

Prikken M, van der Weiden A, Baalbergen H, Hillegers MH, Kahn RS, Aarts H, van Haren NE.

J Psychiatry Neurosci. 2019 May 1;44(3):177-184.

21.

Running in the Family? Structural Brain Abnormalities and IQ in Offspring, Siblings, Parents, and Co-twins of Patients with Schizophrenia.

de Zwarte SMC, Brouwer RM, Tsouli A, Cahn W, Hillegers MHJ, Hulshoff Pol HE, Kahn RS, van Haren NEM.

Schizophr Bull. 2018 Dec 28. doi: 10.1093/schbul/sby182. [Epub ahead of print]

PMID:
30597053
22.

Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry.

Böttcher C, Schlickeiser S, Sneeboer MAM, Kunkel D, Knop A, Paza E, Fidzinski P, Kraus L, Snijders GJL, Kahn RS, Schulz AR, Mei HE; NBB-Psy, Hol EM, Siegmund B, Glauben R, Spruth EJ, de Witte LD, Priller J.

Nat Neurosci. 2019 Jan;22(1):78-90. doi: 10.1038/s41593-018-0290-2. Epub 2018 Dec 17.

PMID:
30559476
23.

Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study.

Swets M, van Dijk FA, Schirmbeck F, Peen J, de Haan L, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, Simons CJP, van Haren NE, van Os J, van Winkel R.

Psychiatry Res. 2019 Jan;271:421-427. doi: 10.1016/j.psychres.2018.11.071. Epub 2018 Dec 3.

PMID:
30537664
24.

Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.

Zhang JP, Robinson D, Yu J, Gallego J, Fleischhacker WW, Kahn RS, Crespo-Facorro B, Vazquez-Bourgon J, Kane JM, Malhotra AK, Lencz T.

Am J Psychiatry. 2019 Jan 1;176(1):21-28. doi: 10.1176/appi.ajp.2018.17121363. Epub 2018 Nov 5. Erratum in: Am J Psychiatry. 2019 Mar 1;176(3):252.

25.

Corrigendum to "Long-term course of negative symptom subdomains and relationship with outcome in patients with a psychotic disorder" [Schizophr. Res. 193 (2018) 173-181].

Stiekema APM, Islam MA, Liemburg EJ, Castelein S, van den Heuvel ER, van Weeghel J, Aleman A, Bruggeman R, van der Meer L; GROUP investigators, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NEM, van Os J, van Winkel R.

Schizophr Res. 2019 Feb;204:462-463. doi: 10.1016/j.schres.2018.10.003. Epub 2018 Oct 9. No abstract available.

PMID:
30314649
26.

The characteristics of psychotic features in bipolar disorder.

van Bergen AH, Verkooijen S, Vreeker A, Abramovic L, Hillegers MH, Spijker AT, Hoencamp E, Regeer EJ, Knapen SE, Riemersma-van der Lek RF, Schoevers R, Stevens AW, Schulte PFJ, Vonk R, Hoekstra R, van Beveren NJ, Kupka RW, Sommer IEC, Ophoff RA, Kahn RS, Boks MPM.

Psychol Med. 2018 Oct 10:1-13. doi: 10.1017/S0033291718002854. [Epub ahead of print]

PMID:
30303059
27.

Microglia innately develop within cerebral organoids.

Ormel PR, Vieira de Sá R, van Bodegraven EJ, Karst H, Harschnitz O, Sneeboer MAM, Johansen LE, van Dijk RE, Scheefhals N, Berdenis van Berlekom A, Ribes Martínez E, Kling S, MacGillavry HD, van den Berg LH, Kahn RS, Hol EM, de Witte LD, Pasterkamp RJ.

Nat Commun. 2018 Oct 9;9(1):4167. doi: 10.1038/s41467-018-06684-2.

28.

Reward-related brain structures are smaller in patients with schizophrenia and comorbid metabolic syndrome.

de Nijs J, Schnack HG, Koevoets MGJC, Kubota M, Kahn RS, van Haren NEM, Cahn W.

Acta Psychiatr Scand. 2018 Dec;138(6):581-590. doi: 10.1111/acps.12955. Epub 2018 Sep 27.

PMID:
30264457
29.

Increased responses of the reward circuitry to positive task feedback following acute stress in healthy controls but not in siblings of schizophrenia patients.

van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH.

Neuroimage. 2019 Jan 1;184:547-554. doi: 10.1016/j.neuroimage.2018.09.051. Epub 2018 Sep 21.

PMID:
30243958
30.

Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.

Okhuijsen-Pfeifer C, Huijsman EAH, Hasan A, Sommer IEC, Leucht S, Kahn RS, Luykx JJ.

Acta Psychiatr Scand. 2018 Oct;138(4):281-288. doi: 10.1111/acps.12954. Epub 2018 Sep 14.

31.

Antipsychotic treatments: who is really failing here? - Authors' reply.

Kahn RS, Sommer IE.

Lancet Psychiatry. 2018 Oct;5(10):785-786. doi: 10.1016/S2215-0366(18)30340-7. Epub 2018 Sep 5. No abstract available.

PMID:
30196054
32.

Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia.

Boks MP, Houtepen LC, Xu Z, He Y, Ursini G, Maihofer AX, Rajarajan P, Yu Q, Xu H, Wu Y, Wang S, Shi JP, Hulshoff Pol HE, Strengman E, Rutten BPF, Jaffe AE, Kleinman JE, Baker DG, Hol EM, Akbarian S, Nievergelt CM, De Witte LD, Vinkers CH, Weinberger DR, Yu J, Kahn RS.

NPJ Schizophr. 2018 Aug 21;4(1):16. doi: 10.1038/s41537-018-0058-4.

33.

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.

Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, Eijkemans MJC, Fleischhacker WW, Kapur S, Sommer IE; OPTiMiSE study group.

Lancet Psychiatry. 2018 Oct;5(10):797-807. doi: 10.1016/S2215-0366(18)30252-9. Epub 2018 Aug 13.

PMID:
30115598
34.

Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia.

Fiksinski AM, Breetvelt EJ, Lee YJ, Boot E, Butcher N, Palmer L, Chow EWC, Kahn RS, Vorstman JAS, Bassett AS.

Psychol Med. 2019 Apr;49(6):1047-1054. doi: 10.1017/S0033291718001824. Epub 2018 Aug 1.

PMID:
30064532
35.

On the Continued Benefit of Antipsychotics After the First Episode of Schizophrenia.

Kahn RS.

Am J Psychiatry. 2018 Aug 1;175(8):712-713. doi: 10.1176/appi.ajp.2018.18060639. No abstract available.

PMID:
30064241
36.

Glucocorticoid receptor exon 1F methylation and the cortisol stress response in health and disease.

Schür RR, van Leeuwen JMC, Houtepen LC, Joëls M, Kahn RS, Boks MP, Vinkers CH.

Psychoneuroendocrinology. 2018 Nov;97:182-189. doi: 10.1016/j.psyneuen.2018.07.018. Epub 2018 Jul 11.

37.

Genome-wide association meta-analysis of age at first cannabis use.

Minică CC, Verweij KJH, van der Most PJ, Mbarek H, Bernard M, van Eijk KR, Lind PA, Liu MZ, Maciejewski DF, Palviainen T, Sánchez-Mora C, Sherva R, Taylor M, Walters RK, Abdellaoui A, Bigdeli TB, Branje SJT, Brown SA, Casas M, Corley RP, Davey-Smith G, Davies GE, Ehli EA, Farrer L, Fedko IO, Garcia-Martínez I, Gordon SD, Hartman CA, Heath AC, Hickie IB, Hickman M, Hopfer CJ, Hottenga JJ, Kahn RS, Kaprio J, Korhonen T, Kranzler HR, Krauter K, van Lier PAC, Madden PAF, Medland SE, Neale MC, Meeus WHJ, Montgomery GW, Nolte IM, Oldehinkel AJ, Pausova Z, Ramos-Quiroga JA, Richarte V, Rose RJ, Shin J, Stallings MC, Wall TL, Ware JJ, Wright MJ, Zhao H, Koot HM, Paus T, Hewitt JK, Ribasés M, Loukola A, Boks MP, Snieder H, Munafò MR, Gelernter J, Boomsma DI, Martin NG, Gillespie NA, Vink JM, Derks EM.

Addiction. 2018 Nov;113(11):2073-2086. doi: 10.1111/add.14368. Epub 2018 Aug 19.

PMID:
30003630
38.

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM.

Oviedo-Salcedo T, de Witte L, Kümpfel T, Kahn RS, Falkai P, Eichhorn P, Luykx J, Hasan A.

Br J Psychiatry. 2018 Sep;213(3):561. doi: 10.1192/bjp.2018.77. Epub 2018 Jul 10.

PMID:
29986772
39.

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, Mueller BA, Cahn W, de Zwarte SMC, Hulshoff Pol HE, Kahn RS, Ophoff RA, van Haren NEM, Andreassen OA, Dale AM, Doan NT, Gurholt TP, Hartberg CB, Haukvik UK, Jørgensen KN, Lagerberg TV, Melle I, Westlye LT, Gruber O, Kraemer B, Richter A, Zilles D, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Carr VJ, Catts S, Cropley VL, Fullerton JM, Green MJ, Henskens FA, Jablensky A, Lenroot RK, Mowry BJ, Michie PT, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Morris DW, Hong E, Kochunov P, Beard LM, Gur RE, Gur RC, Satterthwaite TD, Wolf DH, Belger A, Brown GG, Ford JM, Macciardi F, Mathalon DH, O'Leary DS, Potkin SG, Preda A, Voyvodic J, Lim KO, McEwen S, Yang F, Tan Y, Tan S, Wang Z, Fan F, Chen J, Xiang H, Tang S, Guo H, Wan P, Wei D, Bockholt HJ, Ehrlich S, Wolthusen RPF, King MD, Shoemaker JM, Sponheim SR, De Haan L, Koenders L, Machielsen MW, van Amelsvoort T, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, McKenna PJ, Pomarol-Clotet E, Salvador R, Corvin A, Donohoe G, Kelly S, Whelan CD, Dickie EW, Rotenberg D, Voineskos AN, Ciufolini S, Radua J, Dazzan P, Murray R, Reis Marques T, Simmons A, Borgwardt S, Egloff L, Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Wang L, Jönsson EG, Koops S, Sommer IEC, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Stephen JM, Kwon JS, Yun JY, Cannon DM, McDonald C, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L; Karolinska Schizophrenia Project, Busatto GF, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, Hagenaars SP, McIntosh AM, Whalley HC, Lawrie SM, Knöchel C, Oertel-Knöchel V, Stäblein M, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, McMahon A, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA.

Biol Psychiatry. 2018 Nov 1;84(9):644-654. doi: 10.1016/j.biopsych.2018.04.023. Epub 2018 May 14.

40.

Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE).

Egerton A, Broberg BV, Van Haren N, Merritt K, Barker GJ, Lythgoe DJ, Perez-Iglesias R, Baandrup L, Düring SW, Sendt KV, Stone JM, Rostrup E, Sommer IE, Glenthøj B, Kahn RS, Dazzan P, McGuire P.

Mol Psychiatry. 2018 Nov;23(11):2145-2155. doi: 10.1038/s41380-018-0082-9. Epub 2018 Jun 7.

PMID:
29880882
41.

Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls.

de Nijs J, Meijer JH, de Haan L, Meijer CJ, Bruggeman R, van Haren NEM, Kahn RS, Cahn W.

Psychiatry Res. 2018 Aug;266:147-151. doi: 10.1016/j.psychres.2018.05.009. Epub 2018 May 19.

PMID:
29864614
42.

Perspectives from the Society for Pediatric Research: interventions targeting social needs in pediatric clinical care.

Beck AF, Cohen AJ, Colvin JD, Fichtenberg CM, Fleegler EW, Garg A, Gottlieb LM, Pantell MS, Sandel MT, Schickedanz A, Kahn RS.

Pediatr Res. 2018 Jul;84(1):10-21. doi: 10.1038/s41390-018-0012-1. Epub 2018 May 23. Review.

PMID:
29795202
43.

White matter disruptions in patients with bipolar disorder.

Abramovic L, Boks MPM, Vreeker A, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NEM.

Eur Neuropsychopharmacol. 2018 Jun;28(6):743-751. doi: 10.1016/j.euroneuro.2018.01.001. Epub 2018 May 18.

44.

Double Hits in Schizophrenia.

Vorstman JAS, Olde Loohuis LM; GROUP Investigators, Kahn RS, Ophoff RA.

Hum Mol Genet. 2018 May 14. doi: 10.1093/hmg/ddy175. [Epub ahead of print]

PMID:
29767709
45.

Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia.

Olde Loohuis LM, Mangul S, Ori APS, Jospin G, Koslicki D, Yang HT, Wu T, Boks MP, Lomen-Hoerth C, Wiedau-Pazos M, Cantor RM, de Vos WM, Kahn RS, Eskin E, Ophoff RA.

Transl Psychiatry. 2018 May 10;8(1):96. doi: 10.1038/s41398-018-0107-9.

46.

Comprehensive pathway analyses of schizophrenia risk loci point to dysfunctional postsynaptic signaling.

Schijven D, Kofink D, Tragante V, Verkerke M, Pulit SL, Kahn RS, Veldink JH, Vinkers CH, Boks MP, Luykx JJ.

Schizophr Res. 2018 Sep;199:195-202. doi: 10.1016/j.schres.2018.03.032. Epub 2018 Apr 11.

PMID:
29653892
47.

Intra- and interobserver agreement for fetal cerebral measurements in 3D-ultrasonography.

Albers MEWA, Buisman ETIA, Kahn RS, Franx A, Onland-Moret NC, de Heus R.

Hum Brain Mapp. 2018 Aug;39(8):3277-3284. doi: 10.1002/hbm.24076. Epub 2018 Apr 10.

PMID:
29637664
48.

Poverty, Transportation Access, and Medication Nonadherence.

Hensley C, Heaton PC, Kahn RS, Luder HR, Frede SM, Beck AF.

Pediatrics. 2018 Apr;141(4). pii: e20173402. doi: 10.1542/peds.2017-3402. Epub 2018 Mar 16.

49.

Pervasive Income-Based Disparities In Inpatient Bed-Day Rates Across Conditions And Subspecialties.

Beck AF, Riley CL, Taylor SC, Brokamp C, Kahn RS.

Health Aff (Millwood). 2018 Apr;37(4):551-559. doi: 10.1377/hlthaff.2017.1280.

50.

Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis.

Jézéquel J, Lepleux M, Kahn RS, Honnorat J, Leboyer M, Groc L.

Am J Psychiatry. 2018 Apr 1;175(4):382-383. doi: 10.1176/appi.ajp.2017.17091053. No abstract available.

PMID:
29606071

Supplemental Content

Support Center